GVHD Will not be a great money maker, so regardless of whether...

GVHD Will not be a great money maker, so regardless of whether CYP will take over the market with their cells won’t matter too much to MSB. Just a few points of clarification though, CYP phase 1 is due for completion anyday now, not 2020. The product will most likely be on market by 2020 in Japan given the short time frame to commercialisation of GVHD. They use a completely different (cheaper and more efficient) method for MSc production so patents aren’t an issue. They are two seperate companies with completely different business models.